Lannett Company
LCI
$0.69
Share price
0.00%
Change (1 day)
-69.93%
Change (1 year)
Categories
Lannett Company (LCI) - Cash on Hand
Cash on Hand as of March 2023 : $46.54 M
According to Lannett Company's latest financial reports the company has $46.54 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lannett Company - Cash on Hand chart (from 2002 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-06-30 | $87.85 M | -5.82% |
| 2021-06-30 | $93.28 M | -35.37% |
| 2020-06-30 | $0.14 B | 2.91% |
| 2019-06-30 | $0.14 B | 42.26% |
| 2018-06-30 | $98.58 M | -31.93% |
| 2017-06-30 | $0.14 B | -39.37% |
| 2016-06-30 | $0.23 B | 11.72% |
| 2015-06-30 | $0.21 B | 46.16% |
| 2014-06-30 | $0.14 B | 185.98% |
| 2013-06-30 | $51.15 M | 75% |
| 2012-06-30 | $29.22 M | 18.53% |
| 2011-06-30 | $24.65 M | 9.59% |
| 2010-06-30 | $22.5 M | -14.06% |
| 2009-06-30 | $26.18 M | 318.44% |
| 2008-06-30 | $6.25 M | 20.5% |
| 2007-06-30 | $5.19 M | 1008.62% |
| 2006-06-30 | $0.46 M | -88.76% |
| 2005-06-30 | $4.16 M | -53.54% |
| 2004-06-30 | $8.96 M | 154.13% |
| 2003-06-30 | $3.52 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 56,234.34% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | 20,729.39% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 27,166.87% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 15,540.31% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $5.17 B | 11,019.38% | 🇬🇧 UK |